Cumberland Pharmaceuticals Inc investor relations material

Listen to the latest call from Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, develops, acquires and commercializes prescription products for the treatment of acute pain, gastroenterology, rheumatology and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for direct delivery of azithromycin in combination with amoxicillin and potassium clavulanate to patients with respiratory tract infections caused by H. pylori and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic or hypervolemic hyponatremia; Vibativ (telavancin), which is indicated for the treatment of certain serious bacterial infections involving one or more pathogens caused by Gram-positive microorganisms including methicillin-resistant Staphylococcus aureus (MRSA), as well as complicated skin and skin structure infections caused by Gram-positive microorganisms.

Upcoming events

Previous events

Dig deeper into the Cumberland Pharmaceuticals Inc fundamentals on Quartr.